Form 8-K - Current report:
SEC Accession No. 0001558370-20-005720
Filing Date
2020-05-07
Accepted
2020-05-07 16:16:51
Documents
2
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20200507x8k.htm 8-K 37856
2 EX-99.1 tmb-20200507xex99d1.htm EX-99.1 102376
  Complete submission text file 0001558370-20-005720.txt   141399
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

EIN.: 824592913 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38670 | Film No.: 20856650
SIC: 2834 Pharmaceutical Preparations